BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Percutaneous Aortic Valve Replacement Training Module now Available by Simbionix


1/19/2010 9:46:04 AM

CLEVELAND, Ohio, January 19 /PRNewswire/ -- Simbionix, the world's leading developer of medical simulation systems, introduces its new module for the ANGIO Mentor simulator, the Percutaneous Aortic Valve Replacement Module, which provides physicians with an opportunity to practice a revolutionary endovascular implantation of a bioprosthesis, without performing cardiac surgery.

Percutaneous aortic valve replacement is an innovative minimally invasive technique for heart valve implantation. This procedure, which takes place in a catheterization lab, is performed on a beating heart, so that there is no need for a cardiopulmonary bypass and its associated risks. In addition to having the potential to treat and heal many of the patients who are ineligible for traditional open-heart surgery, including elderly patients or patients suffering from additional conditions, this new technique is also less traumatic to the patient, and reduces healthcare costs and rehabilitation time.

The new training module provides surgeons with the opportunity to practice correct placement of the bioprosthesis during an Aortic Valve Replacement, which is critical for the success of the procedure. Surgeons can train on different virtual patients, and gain experience with complicated anatomies and various pathologies. At the end of the session the surgeon can assess and analyze the deployment process and learn how to work more safely with a bioprosthesis.

Mr. Gary Zamler, Simbionix CEO adds: "The medical device field is rapidly developing, with new technologies continuously being introduced to the market and new techniques being used every day. Based on the work of our exceptionally strong R&D team, we are able to assist clinicians in keeping up with these changes, while at the same time contributing to enhanced patient safety. Device manufactures share the same needs, and require advanced and efficient training tools. Simbionix solutions provide a wide scope of opportunities to attend to this positive trend in medical device developments, an example of which is demonstrated in this new application for percutaneous aortic valve replacement".

About Simbionix USA Corporation

Simbionix is the world's leading provider of simulation and training products for medical professionals and the healthcare industry. Founded in 1997, the company is committed to delivering high quality products, advancing clinical perfomrmance and optimizing procedural outcomes. Simbionix cooperates with physicians on a regular basis to produce the most reliable and effective training and supporting systems.

CONTACT: Rebecca Zitter, Exhibition Manager, Simbionix, Tel :
+1-216-229-2040, galia@simbionix.com


Read at BioSpace.com

Simbionix
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->